We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

68 hedge funds and large institutions have $550M invested in Editas Medicine in 2016 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

238% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 8

110% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 10

39% more funds holding

Funds holding: 49 → 68 (+19)

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

12% less capital invested

Capital invested by funds: $623M → $550M (-$73.3M)

Holders
68
Holders Change
+19
Holders Change %
+38.78%
% of All Funds
1.81%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
27
Increased
21
Reduced
10
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$5.25M
2
State Street
State Street
Massachusetts
+$2.22M
3
Northern Trust
Northern Trust
Illinois
+$1.96M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.69M
5
Renaissance Technologies
Renaissance Technologies
New York
+$752K

Top Sellers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
-$14.4M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$7.33M
3
WCM
Wildcat Capital Management
New York
-$6.34M
4
CC
Casdin Capital
New York
-$2.95M
5
JP Morgan Chase
JP Morgan Chase
New York
-$2.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$422K +$141K +4,191 +32%
Deutsche Bank
27
Deutsche Bank
Germany
$405K +$407K +12,051 +261%
AllianceBernstein
28
AllianceBernstein
Tennessee
$405K +$560K +16,600 New
Millennium Management
29
Millennium Management
New York
$382K +$528K +15,660 New
Squarepoint
30
Squarepoint
New York
$376K +$519K +15,400 New
SG Americas Securities
31
SG Americas Securities
New York
$356K -$637K -18,887 -56%
SG
32
Societe Generale
$356K +$492K +14,597 New
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$351K – – –
SSA
34
Schonfeld Strategic Advisors
New York
$349K +$155K +4,586 +47%
SIM
35
Spark Investment Management
New York
$326K +$452K +13,400 New
TD Asset Management
36
TD Asset Management
Ontario, Canada
$305K – – –
TA
37
Teachers Advisors
New York
$267K +$148K +4,384 +67%
PP
38
Paloma Partners
Connecticut
$252K +$349K +10,333 New
Swiss National Bank
39
Swiss National Bank
Switzerland
$242K +$334K +9,900 New
CIM
40
CIM Investment Management
Pennsylvania
$229K +$316K +9,366 New
BA
41
BlackRock Advisors
Delaware
$215K +$190K +5,622 +175%
MLICM
42
Metropolitan Life Insurance Company (MetLife)
New York
$181K +$251K +7,426 New
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$159K +$219K +6,500 New
Manulife (Manufacturers Life Insurance)
44
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$120K +$165K +4,904 New
NFA
45
Nationwide Fund Advisors
Ohio
$115K +$159K +4,727 New
Wells Fargo
46
Wells Fargo
California
$105K +$77.9K +2,309 +117%
AIG
47
American International Group
New York
$96.5K +$133K +3,955 New
HHMI
48
Howard Hughes Medical Institute
Maryland
$77K +$106K +3,145 New
SO
49
STRS Ohio
Ohio
$53K – – –
Creative Planning
50
Creative Planning
Kansas
$39K +$40.5K +1,200 +299%
1
2
3 4

EDIT Hedge Fund Activity: Q2 2016 in Review

68 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2016, worth a combined $550M — down 12% from $623M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new EDIT positions and 8 closed out — a net gain of 19 holders — while 21 added to existing stakes and 10 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $5.25M. The largest seller was Viking Global Investors, cutting an estimated $14.4M.

  • 68 institutional investors held Editas Medicine (EDIT) as of Q2 2016, up from 49 in Q1 2016.
  • Funds reported $550M of Editas Medicine stock for Q2 2016, down 12% quarter-over-quarter.
  • 27 funds opened new Editas Medicine positions in Q2 2016 and 8 closed out, a net change of +19 holders.
  • The largest Editas Medicine buyer in Q2 2016 was Morgan Stanley, an estimated $5.25M added.
  • The largest Editas Medicine seller in Q2 2016 was Viking Global Investors, an estimated $14.4M sold.

Based on aggregated 13F filings for Q2 2016.